OpenURL Connection Search

Select item for more details and to access through your institution.

Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: The Path to Least Resistance.
Published in:
International Journal of Molecular Sciences, 2018, v. 19, n. 10, p. 3198, doi. 10.3390/ijms19103198
By:
- Staudt, Dilana;
- Murray, Heather C.;
- McLachlan, Tabitha;
- Alvaro, Frank;
- Enjeti, Anoop K.;
- Verrills, Nicole M.;
- Dun, Matthew D.
Publication type:
Article
Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies.
Published in:
Science Signaling, 2023, v. 16, n. 778, p. 1, doi. 10.1126/scisignal.abp9586
By:
- Germon, Zacary P.;
- Sillar, Jonathan R.;
- Mannan, Abdul;
- Duchatel, Ryan J.;
- Staudt, Dilana;
- Murray, Heather C.;
- Findlay, Izac J.;
- Jackson, Evangeline R.;
- McEwen, Holly P.;
- Douglas, Alicia M.;
- McLachlan, Tabitha;
- Schjenken, John E.;
- Skerrett-Byrne, David A.;
- Huang, Honggang;
- Melo-Braga, Marcella N.;
- Plank, Maximilian W.;
- Alvaro, Frank;
- Chamberlain, Janis;
- De Iuliis, Geoff;
- Aitken, R. John
Publication type:
Article
Correction to: Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection.
Published in:
2023
By:
- Staudt, Dilana E.;
- Murray, Heather C.;
- Skerrett-Byrne, David A.;
- Smith, Nathan D.;
- Jamaluddin, M. Fairuz B.;
- Kahl, Richard G. S.;
- Duchatel, Ryan J.;
- Germon, Zacary P.;
- McLachlan, Tabitha;
- Jackson, Evangeline R.;
- Findlay, Izac J.;
- Kearney, Padraic S.;
- Mannan, Abdul;
- McEwen, Holly P.;
- Douglas, Alicia M.;
- Nixon, Brett;
- Verrills, Nicole M.;
- Dun, Matthew D.
Publication type:
Correction Notice
Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection.
Published in:
Clinical Proteomics, 2022, v. 19, n. 1, p. 1, doi. 10.1186/s12014-022-09385-7
By:
- Staudt, Dilana E.;
- Murray, Heather C.;
- Skerrett-Byrne, David A.;
- Smith, Nathan D.;
- Jamaluddin, M. Fairuz B.;
- Kahl, Richard G. S.;
- Duchatel, Ryan J.;
- Germon, Zacary P.;
- McLachlan, Tabitha;
- Jackson, Evangeline R.;
- Findlay, Izac J.;
- Kearney, Padraic S.;
- Mannan, Abdul;
- McEwen, Holly P.;
- Douglas, Alicia M.;
- Nixon, Brett;
- Verrills, Nicole M.;
- Dun, Matthew D.
Publication type:
Article

Found: 4

Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: The Path to Least Resistance.

Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies.

Correction to: Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection.

Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection.